Circadian variation in disease activity in rheumatoid arthritis.

Disease activity in rheumatoid arthritis as measured by repeated estimation of joint pain, stiffness, articular index, and grip strength was shown to have a circadian rythm, maximal activity being seen between 0200 and 0400 and minimal activity in the early afternoon. This variation in disease activity may be related to circadian alterations in immune and inflammatory responses (such as immune complexes and neutrophil function) dependent on alterations in circulating concentrations of steroids. The circadian variation in disease activity has important implications in assessment of patients, prescription of drugs, and performance of drug trials.

[1]  A. Fauci,et al.  Glucocorticosteroid therapy: mechanisms of action and clinical considerations. , 1976, Annals of internal medicine.

[2]  V. Wright,et al.  Scientific assessment of the results of physical treatment--measurement of stiffness. , 1966, Annals of physical medicine.

[3]  C. P. Rhoads,et al.  Hormones and Cancer , 1982, Advances in Experimental Medicine and Biology.

[4]  Chronobiology, pharmacology and the immune system , 1980 .

[5]  R. Zubler,et al.  Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus. , 1976, Journal of immunology.

[6]  A. Reinberg,et al.  Chrono pharmaco kinetics of indomethacin in 9 healthy young human adults , 1977 .

[7]  J. Scott Morning Stiffness in Rheumatoid Arthritis * , 1960, Annals of the rheumatic diseases.

[8]  M. Knapp,et al.  Circadian variation in an immune response in man. , 1978, British medical journal.

[9]  M. Knapp,et al.  Possible effect of time on renal allograft rejection. , 1979, British medical journal.

[10]  M. Knapp,et al.  Circadian variations in the signs and symptoms of rheumatoid arthritis and in the therapeutic effectiveness of flurbiprofen at different times of day. , 1981, British journal of clinical pharmacology.

[11]  D. Morris,et al.  ENCEPHALOPATHY AFTER COMBINED DIPHTHERIA-PERTUSSIS INOCULATION REPORT OF A CASE , 1950 .

[12]  K. Griffiths,et al.  Possible tests for selection of adjuvant systemic therapy in early cancer of the breast , 1980 .